Views:0 Author:Site Editor Publish Time: 2021-04-21 Origin:Site
Since April, the epidemic situation in India has been out of control seriously, and more than 200000 people have been diagnosed with covid-19 for several days in a row, which has led to an extreme shortage of antiviral drugs in the Indian market.
Recently, the Indian government has issued an indefinite export ban on the antiviral drug remdesivir until the epidemic situation is alleviated or lifted. Remdesivir is the only drug approved by FDA for the treatment of new crowns in 2020. India's major pharmaceutical companies are in full swing to produce remdesivir injections. Therefore, the demand for sulfobutyl beta cyclodextrin sodium (SBECD), the excipient of remdesivir, is increasing rapidly. In order to meet the needs of the market and save the patients infected by the covid-19, our factory is stepping up the production of SBEBCD.
Sulfobutyl beta cyclodextrin sodium is a kind of cyclodextrin derivative with high safety and good solubilization effect. It can improve the solubility, bioavailability and stability of drugs, and is widely used in the solubilization of injection drugs. Zhiyuan biotechnology is an enterprise specializing in the production of cyclodextrin derivatives. Our vision is to explore the unlimited application of cyclodextrin in human life. Welcome to contact +86-531-88916568.